Patty Eisenhaur
Investor Relations Kontakt bei MOMENTA PHARMACEUTICALS, INC.
Profil
Patty Eisenhaur is currently working as an Investor Relations Contact at Momenta Pharmaceuticals, Inc. and as a Senior Strategist at EVC Group, Inc. Previously, she worked as the Head-Investor Relations at Curia Global, Inc. from 2014 to 2018.
Aktive Positionen von Patty Eisenhaur
| Unternehmen | Position | Beginn |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
| EVC Group, Inc. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Patty Eisenhaur
| Unternehmen | Position | Ende |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Investor Relations Kontakt | 01.06.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| EVC Group, Inc. | |
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
